Chronic lymphocytic leukemia with eyelid involvement responding to alemtuzumab

J Clin Oncol. 2008 Nov 10;26(32):5299-301. doi: 10.1200/JCO.2008.18.6270. Epub 2008 Oct 14.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Alemtuzumab
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Neoplasm / therapeutic use*
  • Antineoplastic Agents / therapeutic use*
  • Eyelid Neoplasms / drug therapy*
  • Eyelid Neoplasms / pathology
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy*
  • Leukemia, Lymphocytic, Chronic, B-Cell / pathology
  • Male
  • Middle Aged
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Neoplasm
  • Antineoplastic Agents
  • Alemtuzumab